If our hypothesis is borne out in prospective and longitudinal studies, it would provide compelling evidence for a mechanistic bridge between tau, a cardinal pathologic substrate of AD, and cortical atrophy—the common end point of neurodegeneration. The gene discussed is MAPT; the disease is Cerebral cortical atrophy.